The Antifungal Treatment
Market Overview Analysis By Drugs Class
(Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines, And Others), By
Therapeutic Indication (Systemic, Candidiasis, Coccidioidomycosis,
Cryptococcosis, And Prophylactic), By Pathogen (Candida, Aspergillus,
Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton, And Others), And
By End Users (Hospitals & Clinics, Dermatology Clinics, And Others) -
Forecast Till 2030
The global antifungal
treatment market is continually ascending on the growth scale. Significant
factors contributing to the growth of the market include the increasing
awareness about the myriad fungal infections and increasing government &
corporate initiatives to control the symptoms of the conditions. Moreover, the
introduction of breakthrough medicines that have distinctly changed the
approach to antifungal therapy, sometimes even allowing oral treatment of
chronic mycoses, is accelerating the market growth.
According to Market
Research Future (MRFFR), the global antifungal treatment
market size is booming and expected to
garner a valuation of USD 29.08 billion by 2030. In its recent antifungal
treatment market analysis, MRFR also asserts that the market would register a
CAGR of 6.35 % over the assessment period. Increased risk in wear artificial
nails, alongside the people with a weakened immune system and increasing
occurrences of weakened immune systems, foster the antifungal treatment
industry.
Increasing prevalence of
various fungal infections alongside the rise in the number of
immune-compromised aged population and population that come in contact with
resistant fungal strains and infections drive the market growth, significantly.
On the other hand, skepticism towards the efficacy of antifungal medicines
among patients or practitioners is a major growth impeding factor for the
market. Also, government regulations for pharmaceutical production and allergic
reaction to some types of antifungal drugs obstruct market growth.
Mainly, people with a
weakened immune system are vulnerable to invasive fungal infections. People who
are at high risk of acquiring fungal infections include HIV & AIDS patients
and cancer patients who are undergoing high-dose chemotherapy and taking
medicines to suppress the immune system, such as corticosteroids. Also, people
having an organ transplant take immunosuppressant, which make them vulnerable
to fungal infections.
Global Antifungal Treatment
Market - Segments
MRFR has segmented the
market into five main dynamics to widen the scope of understanding,
By Drugs Class
: Azoles, Echinocandins, Pyrimidines, Polyenes, Allylamines, and
others.
By Therapeutic Indication
: Systemic, Coccidioidomycosis, Candidiasis, Cryptococcosis,
Prophylactic, and others.
By Pathogen
: Candida, Cryptococcus, Aspergillus, Coccidioides Immitis,
Trichophyton, Zygomycetes, and others.
By End-users
: Hospitals & Clinics, Dermatology Clinics, and others.
By Regions
: Europe, Americas, Asia Pacific, Middle East & Africa,
and Rest-of-the-World
Global Antifungal Treatment
Market - Regional Analysis
North America leads the
antifungal treatment device market. In 2016, the market accounted for a
significant share, reaching a valuation of USD 5,539.4 MN. This market growth
attributes to the increasing prevalence of immunological diseases and high
healthcare expenditures in the region. Over the forecast period, the North
American antifungal treatment is expected to grow at a substantial CAGR,
creating a considerable revenue pocket.
Europe stands second in terms
of the global antifungal treatment market size size. The flourishing antifungal
treatment device market is significantly impacting the market growth in the
region. Driven by the availability of advanced treatment facilities, skilled
medical professionals, and the adoption of new therapies, the European
antifungal treatment market growth is projected to rise significantly during
the forecast period.
The Asia pacific antifungal
treatment market size is emerging as a rapidly growing market, globally. The increasing
prevalence of HIV is the key factor driving the growth of the antifungal
treatment market in the APAC. Besides, the rising awareness about the
antifungal conditions and the availability of new treatment methods foster the
growth of the market. China is the fastest-growing market, which is estimated
to register 5.24% CAGR during the forecasted period. Also, the Indian
antifungal treatment market shows major growth opportunities with its large
unmet needs.
Global Antifungal Treatment
Market - Competitive Analysis
Characterized by the
presence of several notable players, the global antifungal treatment market
appears to be highly competitive. To gain a considerable market share, these
players incorporate strategic initiatives such as mergers & acquisitions,
collaborations, expansion, and treatment/ technology launch. The high growth
potential demonstrated by the market attracts several new entrants, which in
turn intensifies the competition in the market.
Top players invest substantially
in R&D and clinical trials to develop effective medicines and treatments.
Presently, a growing number of companies are working on the development of new
antifungal medication. Drug manufacturing companies are collaborating with
hospitals to provide better solutions. Increasing the adoption of new drugs,
therapies, and treatment options are strengthening the potential growth of this
market.
Major Players:
Players leading the global
antifungal treatment market include Pfizer Inc. (US), Novartis AG
(Switzerland), Sanofi (France), Astellas (Japan), Merck & Co., Inc. (US),
and Bayer AG (Germany), among others.
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment